, Tracking Stock Market Picks
Enter Symbol:
Davita Inc. (DVA) [hlAlert]

up 136.82 %

Davita Inc. (DVA) rated Buy with price target $100 by UBS

Posted on: Tuesday,  Jul 5, 2011  10:25 AM ET by UBS

UBS rated Buy Davita Inc. (NYSE: DVA) on 07/05/2011. Previously UBS rated Buy Davita Inc. (NYSE: DVA) on 10/08/2007., when
the stock price was $32.37. Since then, Davita Inc. has gained 136.83% as of 08/27/2015's recent price of $76.65.
If you would have followed the previous UBS's recommendation on DVA, you would have gained 136.82% of your investment in 2880 days.

DaVita Inc. is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2008, the Company operated or provided administrative services to 1,449 outpatient dialysis centers located in 43 states and the District of Columbia, serving approximately 112,000 patients. It also provides acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. DaVita Inc?s dialysis and related lab services business accounts for approximately 96% of its consolidated revenues. Other ancillary services and strategic initiatives businesses account for approximately 4% of its consolidated revenues and relate primarily to its core business of providing renal care services. It also provides ancillary services and strategic initiatives, such as infusion therapy services, pharmacy services, vascular access services, disease management services and special needs plans,

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/5/2011 10:25 AM Buy
44.03 50.00
as of 12/30/2011
1 Week down  -0.88 %
1 Month down  -0.48 %
3 Months up  20.96 %
1 YTD up  9.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2010 12:25 PM Buy
35.63 42.50
10/8/2007 10:28 AM Buy
32.37 37.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy